Literature DB >> 6422589

Glucagon stimulates ketone utilization by rat brain slices.

J R Kirsch, L G D'Alecy.   

Abstract

Glucagon has been shown previously to increase further the enhanced tolerance for hypoxia observed in mice with elevated blood ketones. Glucagon is also known to increase blood glucose and to alter directly the metabolism of some (liver) cells. Both the increase in blood glucose and altered cellular metabolism could contribute to the increase in tolerance for hypoxia observed in mice given glucagon in combination with the ketone, beta-hydroxybutyrate. To evaluate the systemic component of this hypothesis, blood glucose, beta-hydroxybutyrate, and glucagon were elevated alone or simultaneously and hypoxic tolerance of mice was measured. To identify possible cellular effects of glucagon on glucose or ketone metabolism, we measured the incorporation of radiolabeled glucose or beta-hydroxybutyrate into CO2 or total lipid in isolated rat brain slices. Both glucagon and glucose increased hypoxic tolerance of ketotic mice but our data do not support the hypothesis that glucagon's action was only through an elevation of blood glucose. In brain slices glucagon stimulated the incorporation of beta-hydroxybutyrate into CO2 both in the presence or absence of additional glucose. These results demonstrate that glucagon has a direct effect on brain metabolism which may contribute to the increased tolerance for hypoxia. They, however, do not exclude the possibility that glucagon is working in addition to increase hypoxic survival in ketotic mice by increasing the availability of glucose to the brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6422589     DOI: 10.1161/01.str.15.2.324

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis.

Authors:  C Marie; A M Bralet; S Gueldry; J Bralet
Journal:  Metab Brain Dis       Date:  1990-06       Impact factor: 3.584

2.  Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.

Authors:  Haruka Okamoto; Katie Cavino; Erqian Na; Elizabeth Krumm; Sun Y Kim; Xiping Cheng; Andrew J Murphy; George D Yancopoulos; Jesper Gromada
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

Review 3.  Cerebral Gluconeogenesis and Diseases.

Authors:  James Yip; Xiaokun Geng; Jiamei Shen; Yuchuan Ding
Journal:  Front Pharmacol       Date:  2017-01-04       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.